How Much Does Ozempic Cost? List Price, Insurance, Savings Card, and Cash Explained

The short answer

The most important thing to understand before you compare prices: Ozempic is approved for type 2 diabetes, not for weight loss on its own. Using it purely for weight management is off-label. That distinction drives coverage. Many commercial and Medicare plans cover Ozempic when it is prescribed for diabetes, while coverage for weight-only use is far less consistent, and the manufacturer savings card typically excludes government insurance such as Medicare and Medicaid. Semaglutide is also sold as Wegovy, which is the version FDA-approved specifically for chronic weight management, and that product has its own separate coverage and savings terms.

This page walks through each cost path, explains why the diabetes-versus-weight distinction changes what you pay, compares the paths in a table, and flags where fabricated or dangerous "cheap Ozempic" offers show up online. Because published prices move, the specific dollar figure you rely on should come directly from the Novo Nordisk savings and NovoCare pages linked at the end, not from a third-party average or a screenshot from a forum.

The short answer: it depends on your cost path, not a fixed number

Ozempic is priced differently for almost everyone who fills it, because a prescription drug in the United States passes through insurance design, manufacturer programs, and pharmacy contracts before you see a copay. The four paths that matter are: the manufacturer list price, your insured copay, the Novo Nordisk savings card, and full cash self-pay. A fifth 'path' you will see advertised, compounded semaglutide, is not the FDA-approved product and is discussed separately below.

Because these paths produce wildly different out-of-pocket costs for the same medicine, the honest answer to 'how much does Ozempic cost' is: identify which path applies to you, then get that path's current number from the source that sets it. For the list price and the savings-card terms, that source is Novo Nordisk, through its NovoCare Ozempic cost-and-coverage page and its Save on Ozempic page.

This site does not sell or prescribe Ozempic and cannot quote you a checkout price. What it can do is show you how the paths differ so you know which question to ask your insurer, your pharmacist, and a licensed prescriber, and so you can recognize when an online offer is too cheap to be the real, FDA-approved drug.

What Ozempic is, and why 'approved for diabetes' changes the price

Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist. According to its FDA prescribing information, Ozempic is approved to improve blood sugar control in adults with type 2 diabetes, and it also has an approved indication to reduce cardiovascular risk in certain patients with type 2 diabetes and known heart disease. It is not FDA-approved as a weight-loss drug. Using Ozempic for weight management alone is off-label prescribing.

That single fact is the hinge of the entire cost question. When Ozempic is prescribed and documented for type 2 diabetes, it falls into a category most insurers are set up to cover, because diabetes medication is a standard, expected benefit. When it is prescribed for weight only, it moves into territory many plans specifically exclude or heavily restrict, which pushes you toward the savings card or cash path.

The semaglutide molecule is also sold as Wegovy, which the FDA has approved for chronic weight management. So the market has two doors for the same active ingredient: a diabetes door (Ozempic) and a weight door (Wegovy), each with its own coverage rules, savings program, and list price. Knowing which door your prescription goes through tells you which pricing rules apply.

Path 1: List price (what the drug 'costs' before anyone helps pay)

The list price, sometimes called the wholesale acquisition cost, is the manufacturer's published starting price before insurance, rebates, or savings programs. It is the number that makes headlines, but it is rarely what an insured patient actually pays. Novo Nordisk publishes Ozempic pricing context on its NovoCare page, and that is the figure to trust because it comes directly from the manufacturer and is updated when it changes.

List price matters most to two groups: people with no insurance who are looking at cash self-pay, and people whose plan uses a high-deductible design where they pay the full negotiated price until a deductible is met. If either describes you, the list price is your realistic starting point, and the savings and self-pay programs below are where you look to bring it down.

Because this figure changes and because quoting a stale number would mislead you, this page does not print a dollar amount. Pull the current list price from the NovoCare Ozempic cost-and-coverage page linked in the sources, and treat any third-party 'average Ozempic price' with skepticism unless it traces back to that manufacturer source.

Path 2: Insured copay (usually the lowest real cost, if the drug is covered)

If your health plan covers Ozempic, your out-of-pocket cost is a copay or coinsurance set by your plan's formulary tier, not the list price. For people whose Ozempic is prescribed for type 2 diabetes, this is often the least expensive path, because diabetes drugs are commonly placed on covered tiers. Your exact copay depends on your specific plan, deductible status, and formulary tier.

Coverage is not automatic even for diabetes. Many plans require prior authorization, meaning your prescriber must document your diagnosis and sometimes that you have tried other diabetes medicines first. Some plans use step therapy. The practical move is to call the member-services number on your insurance card and ask three questions: is Ozempic on the formulary, what tier, and is prior authorization or step therapy required.

For weight-only use, the insured path is where the diabetes-versus-weight gap bites hardest. Plans that readily cover Ozempic for diabetes may deny it, or deny the savings entirely, when the documented reason is weight. This is a frequent, frustrating surprise, and it is why the weight-approved product (Wegovy) sometimes has a cleaner coverage story than off-label Ozempic.

Path 3: The manufacturer savings card (commercial insurance, with exclusions)

Novo Nordisk runs a savings offer for Ozempic, described on its Save on Ozempic page. Manufacturer savings cards can substantially reduce what eligible, commercially insured patients pay, but they come with eligibility rules that catch many people off guard. The exact savings amount, caps, and terms are published by Novo Nordisk and change, so the Save on Ozempic page is the only figure to rely on.

The most important eligibility rule on most manufacturer savings cards is that they require commercial (employer or individual-market) insurance and typically exclude government insurance, including Medicare, Medicaid, TRICARE, and other federal or state programs. If you are on Medicare or Medicaid, you generally cannot use the savings card, which changes your best path entirely. Confirm your status against the terms printed on the Save on Ozempic page before you count on it.

Savings cards also usually have per-fill and annual maximums, and they may behave differently depending on whether your plan covers the drug at all. Read the terms rather than assuming a card turns any prescription into a low flat cost. When it applies to you, it is often the difference between an affordable and an unaffordable month.

Path 4: Cash self-pay (no insurance, or coverage denied)

If you have no insurance, or your plan denies Ozempic for your situation, cash self-pay means paying the pharmacy's price without a plan reducing it. Novo Nordisk's NovoCare resources describe the manufacturer's own cost and access options, which is where to look first rather than assuming the list price is your only choice.

Self-pay is where people are most tempted by too-good-to-be-true online prices, and where the risk of getting an unapproved or counterfeit product is highest. A genuine FDA-approved Ozempic pen dispensed by a licensed US pharmacy has a real, non-trivial cost. An offer dramatically below the manufacturer's published pricing is a signal that the product may be compounded, imported without oversight, or counterfeit.

If cash cost is a barrier, the more durable moves are: ask a licensed prescriber whether a weight-approved or diabetes-appropriate alternative fits your clinical situation and has better coverage, and check patient-assistance eligibility through the manufacturer's NovoCare program rather than chasing the cheapest listing on the internet.

Compounded semaglutide: not the same product, and not FDA-approved

Compounded semaglutide is frequently advertised online at prices far below brand Ozempic, but it is not an FDA-approved product. The FDA has warned about unapproved and compounded GLP-1 products, and the availability of compounded versions has shifted along with the drugs' shortage status. A compounded product is not the same thing as a discounted version of the branded drug.

Compounding pharmacies do not go through the FDA approval process that verifies a specific product's safety, effectiveness, quality, and consistent dosing. That means a compounded semaglutide vial can differ in concentration, purity, and instructions from the pen a manufacturer produces, and errors in self-dosing from vials have been a documented safety concern.

Treat a compounded-semaglutide price as a different product with a different risk profile, not as a cheaper Ozempic. If cost is pushing you toward compounded GLP-1 sold online, that is exactly the moment to talk to a licensed prescriber about safe, FDA-approved options and legitimate savings programs instead.

Compare the cost paths at a glance

The table below summarizes how the paths differ. It intentionally does not print dollar figures, because the only trustworthy numbers are the current ones on the manufacturer's pages, and printing a stale amount would mislead. Use it to identify your path, then pull the live figure from the sources.

Read the table as a decision tool: find the row that matches your insurance and diagnosis, then follow the 'where the number lives' column to the correct source. Most people qualify for more than one path and should compare the insured copay against the savings-card price to see which is lower.

Why coverage differs so sharply for diabetes vs weight

Insurers build formularies around FDA-approved uses. Ozempic's approved use is type 2 diabetes, so plans generally have a defined pathway to cover it for that diagnosis. Weight management is a different, and historically less consistently covered, benefit category, and many plans either exclude anti-obesity medications or apply strict criteria.

Because Ozempic itself is not FDA-approved for weight, a prescription documented as 'for weight loss' can fall outside what a plan will pay, even when the same plan covers Ozempic for diabetes. This is not the pharmacy being difficult; it reflects how the drug's approved indication maps onto benefit design. It is the core reason a weight-focused patient may pay dramatically more for off-label Ozempic than a diabetes patient pays for the identical pen.

This is also why the weight-approved semaglutide product, Wegovy, exists as a separate route. If weight is your clinical goal, a licensed prescriber may determine that the drug approved for that use has a clearer coverage and savings pathway than using Ozempic off-label. That is a clinical and coverage conversation, not a decision to make at an online checkout.

How the semaglutide products relate: Ozempic, Wegovy, and the tirzepatide siblings

Understanding the product map keeps you from overpaying or comparing the wrong prices. Ozempic and Wegovy are both semaglutide from Novo Nordisk: Ozempic is approved for type 2 diabetes, Wegovy for chronic weight management. Mounjaro and Zepbound are the tirzepatide equivalents from Lilly: Mounjaro for type 2 diabetes, Zepbound for weight management. Each has its own list price, coverage, and savings page.

For the weight-management drugs, the FDA label eligibility is a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia. Those criteria come from the drug labels' Indications sections and matter because coverage for weight-approved products often mirrors them.

One women's-health distinction is worth carrying into any cost decision: the tirzepatide products (Zepbound and Mounjaro) carry a label warning that they can reduce the effectiveness of oral contraceptives, while semaglutide does not carry that warning. That does not change Ozempic's price, but it is a reason the choice of GLP-1 belongs with a prescriber who knows your full picture, not with whichever product is cheapest that week.

Ozempic, menopause, and midlife weight: a note for women

Weight changes around perimenopause and menopause send many women searching for GLP-1 medications, and cost is usually the first question. It is worth separating two things: menopause hormone therapy and GLP-1 medications are different treatments for different problems, and their costs are not interchangeable. For hormone-therapy cost questions, our dedicated cost pages and ACOG's patient guidance on hormone therapy are the better references.

A GLP-1 like Ozempic is a diabetes medicine that some clinicians use off-label for weight, while menopause hormone therapy addresses menopausal symptoms; one is not a substitute for the other, and neither should be chosen on price alone. If you are weighing both, that is precisely the kind of decision to bring to a licensed clinician who can look at your diagnosis, other medications, and goals together.

If your interest is specifically weight, remember the coverage logic above: the weight-approved products may have a more predictable cost path than off-label Ozempic, and eligibility for those follows the BMI criteria printed on their labels. The cheapest path on paper is not always the appropriate one clinically.

The legitimate way to get Ozempic priced and prescribed online

Ozempic is prescription-only. A legal telehealth path looks like this: you complete a medical intake, a clinician licensed in your state reviews your history and determines whether Ozempic (or a more appropriate alternative) is suitable, and if prescribed, the prescription is filled by a licensed US pharmacy. At no legitimate point can you simply add an FDA-approved Ozempic pen to a cart and check out without a prescriber involved.

This site is affiliate-only: it does not sell or prescribe Ozempic. Where it can help is by letting you compare telehealth providers licensed in your state, so you can start the eligibility and prescriber conversation through a legitimate channel rather than an anonymous seller. Pricing you see through a legitimate provider still routes back to the same underlying paths: insurance, savings card, or self-pay.

Avoid any site that offers to ship Ozempic with no prescription, no clinician review, or from overseas without oversight. 'No prescription needed' for a prescription-only drug is a defining marker of an illegitimate or counterfeit-risk seller, regardless of how professional the website looks.

How to get your actual number today

Do this in order. First, determine your diagnosis and whether the prescription is for diabetes or weight, because that decides which coverage rules apply. Second, call your insurer's member services and ask whether Ozempic is on the formulary, at what tier, and whether prior authorization or step therapy is required. Third, check the Novo Nordisk Save on Ozempic page to see whether you are eligible for the savings card and what its current terms are. Fourth, if uninsured or denied, look at the NovoCare Ozempic page and its assistance options rather than the open internet.

Compare the resulting numbers. Many people find their insured copay and their savings-card price differ, and the lower of the two is their real cost. If neither is workable, that is the signal to have a prescriber-level conversation about weight-approved alternatives or diabetes-appropriate options with better coverage, not to chase a compounded or no-prescription listing.

Throughout, treat the manufacturer pages as the source of truth for any dollar figure, and assume published prices change. A number from a forum post, an ad, or a months-old article is not a substitute for the live figure on the NovoCare and Save on Ozempic pages.

Frequently asked questions

What is the actual cost of Ozempic per month?

There is no single monthly cost, because it depends on your path: list price, insured copay, the Novo Nordisk savings card, or cash self-pay. An insured diabetes patient may pay a modest copay, while an uninsured patient faces the full list price. Get the current figure from Novo Nordisk's NovoCare Ozempic page and the Save on Ozempic page, and expect it to change over time.

Does insurance cover Ozempic for weight loss?

Often no. Ozempic is FDA-approved for type 2 diabetes, and using it for weight alone is off-label. Many plans that cover Ozempic for diabetes will deny it, or the savings, when the documented reason is weight. The semaglutide product FDA-approved for weight management is Wegovy, which may have a clearer coverage path if weight is your goal. Check your specific plan's formulary and criteria.

Can I use the Ozempic savings card if I have Medicare or Medicaid?

Generally no. Manufacturer savings cards typically require commercial insurance and exclude government coverage such as Medicare, Medicaid, and TRICARE. If you are on a government plan, the savings card usually does not apply, which changes your best path. Confirm the current eligibility terms directly on the Save on Ozempic page before relying on it.

Why is compounded semaglutide so much cheaper than Ozempic?

Because it is not the same product. Compounded semaglutide is not FDA-approved, and the FDA has warned about unapproved and compounded GLP-1 products. Compounded versions do not go through the FDA approval process that verifies quality, potency, and dosing, so a low price reflects a different, higher-risk product, not a discount on the branded drug. Discuss FDA-approved options with a licensed prescriber.

Is Ozempic cheaper than Wegovy?

It is not that simple. They are the same molecule (semaglutide) but different approved uses, list prices, coverage rules, and savings programs. For a diabetes diagnosis, Ozempic may be well covered; for weight, Wegovy may have a more predictable coverage path than off-label Ozempic. Compare each product's own manufacturer pricing and your plan's formulary rather than assuming one is universally cheaper.

Can I buy Ozempic online without a prescription?

No. Ozempic is prescription-only. A legitimate telehealth path requires a clinician licensed in your state to review your history and prescribe if appropriate, with the prescription filled by a licensed US pharmacy. Any site offering Ozempic with no prescription or no clinician review is a red flag for an unapproved or counterfeit product, regardless of how the site looks.

Does Ozempic affect birth control like the tirzepatide medications do?

The tirzepatide products (Zepbound and Mounjaro) carry a label warning that they can reduce oral-contraceptive effectiveness. Semaglutide, the active ingredient in Ozempic, does not carry that warning on its label. This does not change Ozempic's price, but it is one reason the choice of GLP-1 should be made with a licensed prescriber who knows your full medical picture.

Primary sources

1. FDA Prescribing Information, Ozempic (semaglutide) injection.
2. NovoCare, Ozempic cost & coverage.
3. Novo Nordisk, Save on Ozempic.
4. FDA Prescribing Information, Wegovy (semaglutide) injection.
5. NovoCare, Wegovy cost & coverage.
6. FDA Prescribing Information, Zepbound (tirzepatide) injection.
7. FDA Prescribing Information, Mounjaro (tirzepatide) injection.
8. NIDDK (NIH), Prescription Medications to Treat Overweight & Obesity.
9. ACOG, Hormone Therapy for Menopause (patient FAQ).
10. FDA Drugs@FDA approved-drug database.